I-Mab Honored with Top Rankings by Institutional Investor

Retrieved on: 2021-06-30 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

I-Mab Honored with Top Rankings by Institutional Investor. View article details on hiswai:

Excerpt

SHANGHAI and GAITHERSBURG, Md., June 30, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical ...

Article found on: www.prnewswire.com